Deepak Singh highlights a recent startup school hosted by Y Combinator, a California-based seed capital company, and wonders whether bioscience will ever follow suit. The "possibilities of collaboration, recognition and/or potential business opportunities" are the main reason why VCs and scientists should start interacting more informally, he says.